Fort Washington Investment Advisors Inc. OH Acquires 19,305 Shares of Merit Medical Systems, Inc. $MMSI

Key Points

• Fort Washington Investment Advisors increased its stake in Merit Medical by 6.4%, buying 19,305 shares to hold 321,023 shares (about 0.54% ownership) valued at roughly $28.3 million.
• Merit Medical beat quarterly expectations with $1.04 EPS (vs. $0.96 est.) and $393.94M revenue (up 10.9% YoY), and issued FY2026 guidance of 4.010–4.150 EPS.
• Institutional investors hold 99.66% of the stock, and analysts' consensus is a "Moderate Buy" with an average target price of $101.25.

Fort Washington Investment Advisors Inc. OH boosted its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) by 6.4% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 321,023 shares of the medical instruments supplier's stock after acquiring an additional 19,305 shares during the period. Fort Washington Investment Advisors Inc. OH owned 0.54% of Merit Medical Systems worth $28,295,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Tudor Investment Corp ET AL acquired a new position in Merit Medical Systems in the third quarter valued at about $2,913,050,000. Assenagon Asset Management S.A. acquired a new position in shares of Merit Medical Systems during the 3rd quarter worth about $1,644,000. Norges Bank acquired a new position in shares of Merit Medical Systems during the 2nd quarter worth about $53,697,000. Westwood Holdings Group Inc. increased its stake in shares of Merit Medical Systems by 11.9% in the 2nd quarter. Westwood Holdings Group Inc. now owns 768,970 shares of the medical instruments supplier's stock valued at $71,883,000 after acquiring an additional 81,469 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Merit Medical Systems by 7.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 917,122 shares of the medical instruments supplier's stock valued at $76,332,000 after acquiring an additional 64,920 shares during the last quarter. Institutional investors and hedge funds own 99.66% of the company's stock.

Merit Medical Systems Price Performance

Shares of NASDAQ MMSI opened at $68.73 on Friday. The company has a fifty day moving average price of $76.85 and a 200 day moving average price of $82.28. The firm has a market cap of $4.08 billion, a PE ratio of 32.42, a PEG ratio of 2.00 and a beta of 0.62. The company has a current ratio of 4.34, a quick ratio of 2.95 and a debt-to-equity ratio of 0.46. Merit Medical Systems, Inc. has a 1-year low of $66.34 and a 1-year high of $107.27.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last released its quarterly earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.08. The firm had revenue of $393.94 million for the quarter, compared to the consensus estimate of $390.77 million. Merit Medical Systems had a return on equity of 13.82% and a net margin of 8.48%.The company's revenue for the quarter was up 10.9% on a year-over-year basis. During the same quarter last year, the business posted $0.93 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Research analysts predict that Merit Medical Systems, Inc. will post 3.37 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms recently weighed in on MMSI. Weiss Ratings reissued a "hold (c)" rating on shares of Merit Medical Systems in a research note on Monday, December 29th. Wells Fargo & Company downgraded shares of Merit Medical Systems from an "overweight" rating to an "equal weight" rating and lowered their target price for the company from $95.00 to $78.00 in a research note on Thursday, February 26th. Wall Street Zen upgraded shares of Merit Medical Systems from a "buy" rating to a "strong-buy" rating in a report on Saturday. Barrington Research lifted their price target on shares of Merit Medical Systems from $106.00 to $109.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 25th. Finally, Needham & Company LLC decreased their price target on shares of Merit Medical Systems from $108.00 to $101.00 and set a "buy" rating for the company in a report on Wednesday, February 25th. Seven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $101.25.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company's product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.